GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » North China Pharmaceutical Co Ltd (SHSE:600812) » Definitions » Cyclically Adjusted FCF per Share

North China Pharmaceutical Co (SHSE:600812) Cyclically Adjusted FCF per Share : ¥0.04 (As of Mar. 2024)


View and export this data going back to 1994. Start your Free Trial

What is North China Pharmaceutical Co Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

North China Pharmaceutical Co's adjusted free cash flow per share for the three months ended in Mar. 2024 was ¥0.227. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ¥0.04 for the trailing ten years ended in Mar. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of North China Pharmaceutical Co was 47.70% per year. The lowest was -45.50% per year. And the median was -31.00% per year.

As of today (2024-06-23), North China Pharmaceutical Co's current stock price is ¥4.13. North China Pharmaceutical Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was ¥0.04. North China Pharmaceutical Co's Cyclically Adjusted Price-to-FCF of today is 103.25.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of North China Pharmaceutical Co was 132.00. The lowest was 95.58. And the median was 119.75.


North China Pharmaceutical Co Cyclically Adjusted FCF per Share Historical Data

The historical data trend for North China Pharmaceutical Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

North China Pharmaceutical Co Cyclically Adjusted FCF per Share Chart

North China Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.56 -0.36 -0.24 -0.08 -

North China Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.05 -0.04 - - 0.04

Competitive Comparison of North China Pharmaceutical Co's Cyclically Adjusted FCF per Share

For the Drug Manufacturers - Specialty & Generic subindustry, North China Pharmaceutical Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


North China Pharmaceutical Co's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, North China Pharmaceutical Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where North China Pharmaceutical Co's Cyclically Adjusted Price-to-FCF falls into.



North China Pharmaceutical Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, North China Pharmaceutical Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.227/115.2271*115.2271
=0.227

Current CPI (Mar. 2024) = 115.2271.

North China Pharmaceutical Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -0.094 98.200 -0.110
201409 0.038 98.900 0.044
201412 0.095 99.000 0.111
201503 -0.061 99.900 -0.070
201506 0.052 99.500 0.060
201509 -0.123 100.500 -0.141
201512 -0.043 100.600 -0.049
201603 -0.035 102.200 -0.039
201606 -0.228 101.400 -0.259
201609 -0.098 102.400 -0.110
201612 -0.066 102.600 -0.074
201703 -0.037 103.200 -0.041
201706 -0.037 103.100 -0.041
201709 -0.032 104.100 -0.035
201712 0.045 104.500 0.050
201803 0.102 105.300 0.112
201806 0.142 104.900 0.156
201809 -0.065 106.600 -0.070
201812 -0.012 106.500 -0.013
201903 0.047 107.700 0.050
201906 0.011 107.700 0.012
201909 0.026 109.800 0.027
201912 -0.029 111.200 -0.030
202003 -0.052 112.300 -0.053
202006 0.056 110.400 0.058
202009 0.050 111.700 0.052
202012 -0.210 111.500 -0.217
202103 -0.060 112.662 -0.061
202106 0.043 111.769 0.044
202109 0.178 112.215 0.183
202112 0.137 113.108 0.140
202203 -0.040 114.335 -0.040
202206 0.055 114.558 0.055
202209 0.064 115.339 0.064
202212 0.188 115.116 0.188
202303 0.039 115.116 0.039
202306 -0.036 114.558 -0.036
202309 0.121 115.339 0.121
202312 0.147 114.781 0.148
202403 0.227 115.227 0.227

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


North China Pharmaceutical Co  (SHSE:600812) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

North China Pharmaceutical Co's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=4.13/0.04
=103.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of North China Pharmaceutical Co was 132.00. The lowest was 95.58. And the median was 119.75.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


North China Pharmaceutical Co Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of North China Pharmaceutical Co's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


North China Pharmaceutical Co (SHSE:600812) Business Description

Traded in Other Exchanges
N/A
Address
No. 388 Heping East Road, Shijiazhuang, Hebei, CHN, 050015
North China Pharmaceutical Co Ltd is engaged in the manufacture and sale of antibiotics, vitamins, and pharmaceutical products in China. The main products include antibiotics such as penicillin, vitamins, cephalosporins, streptomycin, biotechnological drugs, new preparations, and biological products.
Executives
Gao Ren Long senior management
Lian Fa Zhe Director

North China Pharmaceutical Co (SHSE:600812) Headlines

No Headlines